Skip to content
10-Q

Quarterly Report

TherapeuticsMD, Inc. TXMD

0001213900-26-055081

← back to feed
Filed
May 12, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 11, 2026 11.57M sh
Shares Diluted Q1 2026 · Mar 31, 2026 11.64K sh
Shares Diluted restated Q1 2026 · Mar 31, 2025 11.55K sh
Stockholders Equity Q1 2026 · Mar 31, 2026 $26.97M
Stockholders Equity Q1 2026 · Dec 31, 2025 $26.88M
Stockholders Equity Q1 2026 · Mar 31, 2025 $26.74M
Stockholders Equity Q1 2026 · Dec 31, 2024 $27.37M
Current Liabilities Q1 2026 · Mar 31, 2026 $4.91M
Current Liabilities Q1 2026 · Dec 31, 2025 $4.79M
Total Liabilities Q1 2026 · Mar 31, 2026 $10.61M
Total Liabilities Q1 2026 · Dec 31, 2025 $10.78M
Current Assets Q1 2026 · Mar 31, 2026 $15.26M
Current Assets Q1 2026 · Dec 31, 2025 $14.45M
Total Assets Q1 2026 · Mar 31, 2026 $37.58M
Total Assets Q1 2026 · Dec 31, 2025 $37.66M
Eps Diluted Q1 2026 · Mar 31, 2026 $0.01
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.06
Eps Basic Q1 2026 · Mar 31, 2026 $0.01
Eps Basic Q1 2026 · Mar 31, 2025 −$0.06
Net Income Q1 2026 · Mar 31, 2026 $95K
Net Income Q1 2026 · Mar 31, 2025 −$653K
Operating Income Q1 2026 · Mar 31, 2026 −$723K
Operating Income restated Q1 2026 · Mar 31, 2025 −$1.28M